USPTO serial 86465366
STRATACOR
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BESCH, JAY C
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with STRATACOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ruth Rivard
Ruth Rivard Stinson Leonard Street LLP150 South 5th Street, Ste 2300Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for prevention and treatment of medical, dental, and vision conditions, diseases and disorders, namely, for treatment of viral and infectious disease, bacteria-based disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorder; pharmaceuticals for prevention and treatment of conditions, diseases and disorders of animals, namely, for the prevention and treatment of infectious disease, blood disorders, cancer, pain, inflammation, and skin conditions; pharmaceutical preparations for prevention and treatment of medical, dental, and vision conditions, diseases and disorders, namely, for treatment of viral and infectious disease, bacteria-based disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorder; pharmaceutical preparations for prevention and treatment of conditions, diseases and disorders of animals, namely, for the prevention and treatment of infectious disease, blood disorders, cancer, pain, inflammation, and skin conditions; sanitary preparations, namely, sanitary preparations for medical use, sanitary sterilizing preparations; chemical preparations for sanitary purposes; dietary and nutritional supplements; medications for prevention and treatment of medical, dental, and vision conditions, diseases and disorders, namely, for treatment of viral and infectious disease, bacteria-based disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorder; medications for prevention and treatment of conditions, diseases and disorders of animals, namely, for the prevention and treatment of infectious disease, blood disorders, cancer, pain, inflammation, and skin conditions; medicinal herbal preparations; adhesives, namely, adhesives for dental and dentistry use, medical adhesives for binding wounds and internal tissues; medicinal oils; vitamin oils for human consumption; medicinal oils for veterinary use; medicated gels, namely, antibacterial alcohol skin sanitizer gels, anti-inflammatory gels, electrophoresis gels for medical purposes, gels for dermatological use, teething gels, ultrasound gel; non-medicated gels, namely, non-medicated topical gels for the prevention and treatment of allergies, cold and flu; gels for use as personal lubricant; topical first aid gels; medicated gels for veterinary use, namely, antibacterial alcohol skin sanitizer gels, anti-inflammatory gels, electrophoresis gels for veterinary purposes, gels for dermatological use, teething gels, ultrasound gel; medicinal creams, namely, hydrocortisone cream, skin creams for diabetics, medicated creams for treating dermatological conditions, antibiotic creams, antifungal creams, anti-itch cream, topical analgesic creams; medicinal creams for skin care; medicinal creams for veterinary use, namely, hydrocortisone cream, skin creams for diabetics, medicated creams for treating dermatological conditions, antibiotic creams, antifungal creams, anti-itch cream, topical analgesic creams; medicated ointments, namely, anti-inflammatory ointment, anti-itch ointment, medicated ointment for treating dermatological conditions, mentholated ointment for medical use, mercurial ointments for medical use, medicated sunburn ointments; antibiotic ointments; medicated ointments for veterinary use, namely, anti-inflammatory ointment, anti-itch ointment, medicated ointment for treating dermatological conditions, mentholated ointment for medical use, mercurial ointments for medical use, medicated sunburn ointments; medicated lotions for skin, hair, sunburn, face and body; pharmaceutical skin lotions, antibacterial hand lotions, calamine lotion, medicated lotions for treating dermatological conditions; medicated lotions for veterinary use, namely, veterinary pharmaceutical skin lotions, medicated lotions for treating dermatological conditions; medicated sprays, namely, cooling sprays for medical purposes, medicated throat sprays; antibacterial sprays, anti-inflammatory sprays, nasal spray preparations; therapeutic sprays to sooth and relax the muscles; medicated sprays for veterinary use, namely, cooling sprays for medical purposes, sprays for the preventing flea and tick bites; nasal rinses; medicated rinses for veterinary use, namely, for the prevention and treatment of infections and wounds; medicated salves, namely, for the relief of aches and pains; anti-inflammatory salves; multipurpose medicated mentholated salve; medicated salves for veterinary use, namely, for the relief of aches and pains; medicated bath salts; smelling salts; mineral salts for medical purposes; medicated mineral salts for veterinary use; balms for medical and pharmaceutical purposes; balms for veterinary use; bandages, namely, adhesive bandages, antiseptic liquid bandages, bandages for dressings, bandages for skin wounds, surgical bandages; biological preparations for prevention and treatment of medical, dental, and vision conditions, diseases and disorders, namely, for treatment of viral and infectious disease, bacteria-based disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorder; biological preparations for prevention and treatment of conditions, diseases and disorders of animals, namely, for the prevention and treatment of infectious disease, blood disorders, cancer, pain, inflammation, and skin conditions; dressings, namely, medical and surgical dressings, self-adhesive dressings, wound dressings; cells for medical, dental, or clinical use; cells for veterinary use; chemical preparations for pharmaceutical, medical, dental, and veterinary purposes, namely, for treatment of viral and infectious disease, bacteria-based disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorder; disinfectants, namely, all-purpose disinfectants, disinfectants for hygiene and sanitary purposes; disinfectants for medical, dental, vision and veterinary instruments; washes, namely, eye washes, medicated hand and mouth washes, saline wash for medical purposes, vaginal washes, veterinary washes, namely, sanitizing wash for veterinary purposes; compresses, namely, eye compresses, medicated compresses; drops, namely, anti-cough drops, ear drops, eye drops, nose drops, vitamin drops, and medicinal preparations for the mouth to be applied in the form of drops; drops for veterinary uses, namely, ear drops, eye drops, nose drops, vitamin drops, and medicinal preparations for the mouth to be applied in the form of drops; implants consisting of living tissue; first aid supplies, namely, first aid kits, bandages for skin wounds, antibiotic preparations, sanitary sterilizing preparations, gauze; medicines for dental purpose; medicated dental rinses; dental impression materials; ocular pharmaceuticals; dental adhesives; dental alloys; dental amalgams; dental blanks; dental cement; dental composite materials; dental lacquer; dental polish; dental mastics; dental sealants; dental restoration compounds; dental wax; denture adhesives; anti-cavity dental coating preparations containing fluoride; bonding and primer materials for dental purposes; ceramic materials for dental use for fillings; composite materials for dental and dental technical purposes; gases for medical and dental use; medicated anti-cavity dental rinses; medicated dental floss; rubber for dental purposes; sealing agents for dental purposes; synthetic materials for dental use for fillings; alcohol for medicinal purposes; alcohol for pharmaceutical purposes; alcohol for topical use; amalgam for dental purposes; antibacterial substances for medical purposes; antiseptics; anti-cavity fluoride gels for use by dentists; bacterial and bacteriological preparations for medical or veterinary purposes; bone cement for medical purposes; bone fillers consisting of living materials; bone growth media consisting of biological materials for medical purposes; bone morphogenetic protein for use as a bone growth media; bone paste for medical purposes; bone void fillers consisting of biological materials; chemical reagents for medical or veterinary purposes; cleansing solutions for medical use; dental abrasives; dental bite registration materials; dental ceramics; dental compounds used in endodontic procedures; dental porcelain materials; dental resin cement; dental resin for temporary bridges, crowns and veneers; dental tablets for disclosing plaque and tartar on the teeth; dental varnish for use by dentists; dental veneers; diagnostic agents, preparations and substances for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medicinal use; fissure sealant for dental and dental technical purposes; fixing materials for dental purposes; lining materials for dental purposes; material for repairing teeth and for dental crowns and bridges; material for stopping teeth; material for tooth crowns and tooth bridges for dental and dental technical purposes; materials for artificial teeth; materials for crowns and bridges for dental use and for oral prophylaxis; materials for dental fillings and for sealing purposes; materials for making dental impressions; materials for tooth restoration; medical and surgical plasters; medical and surgical dressings; medical diagnostic reagents; medicated moisturizers; medicated mouth care and treatment preparations; medicated mouth wash; medicated toothpaste; metal primers for dental purposes; modeling wax for dental purposes; molding wax for dentists' use; mouth cavity cleansers; natural biomaterials for augmentation of bone and tissue for medical purposes; orthodontic alginate for dental impressions; porcelain for dental prostheses; pre-filled dental trays for applying dental compositions to teeth; stem cells for medical purposes; surgical implants comprising living tissue; surgical mesh comprised primarily of living tissue; teeth filling material; vaccines; vitamin and mineral supplements; vitamin and mineral preparations for medical use; Minerals for use in the medical, dental, vision, health, healthcare, veterinary, wellness, cosmetic, and pharmaceutical fields, namely, mineral salts for medical purposes, mineral preparations for medical purposes, mineral supplements; Plant and herb extracts for use in the medical, dental, vision, health, healthcare, veterinary, wellness, and pharmaceutical fields, namely, plant and herb extracts for medical, veterinary and pharmaceutical purposes; Implants comprising living tissue | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 10, 2017 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 10, 2017 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 20, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 20, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 6, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 22, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 3, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 27, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 27, 2016 | ALIE | ASSIGNED TO LIE | — |
| May 27, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 27, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 27, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 28, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 2, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 2, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 2, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 17, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 16, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 29, 2014 | NWAP | NEW APPLICATION ENTERED | — |